Four fentanyl derivatives (ANQ 3295, ANQ 3296, ANQ 3326 and ANQ 3463), similar in structure to the novel opioid mirfentanil (1,2,3), were examined in rhesus monkeys for their discriminative stimulus, analgesic and positive reinforcing effects. Under some conditions all of the fentanyl derivatives had opioid agonist actions whereas under other conditions some of the compounds had opioid agonist actions while others had opioid antagonist actions. Collectively, data from several assays are consistent with the view that these compounds vary with regard to efficacy at mu opioid receptors. Moreover, the compounds that appeared to have low opioid efficacy had analgesic effects that were not attenuated by oploid antagonists and that were not associated with decreases in respiratory function.
MIRFENT~B~IIL ANQ 3326
ANQ 3295 ANQ 3295
ANQ 3463
The procedures used to assess discriminative stimulus effects, analgesic effects and positive reinforcing effects have been described elsewhere (3, 4, 5) . For studies on positive reinforcing effects, rhesus monkeys were prepared with chronic, indwelling i.v. catheters. During twice daily sessions monkeys could receive injections of various doses of alfentanil, one of the four fentanyl derivatives, or saline. During drug tests, a different dose was available in each of the four, discrete components comprising a session. Each fentanyl derivative was studied alone and in the presence of the opioid antagonist quadazocine. In drug discrimination studies separate groups of monkeys discriminated between saline and either nalbuphine (0.178 mg/kg) or naltrexone (0.032 mg/kg) while responding under a fixed-ratio schedule of stimulus-shock termination. Monkeys that discriminated between naltrexone and saline also received dally injections of 3.2 mg/kg of morphine 3 hours prior to daily sessions. Compounds were assessed for their ability to substitute for nalbuphine or naltrexone and to reverse naltrexone-lever responding in monkeys acutely deprived of morphine. In studies on analgesic effects, the lower 8-10 cm of the shaved tail was immersed in a thermos containing warm (50 or 55" C.) water and the time for monkeys to remove the tall from the thermos was recorded. yes partial agonist no effect opioid/non-opioid ANQ 3296 yes no effect no effect opioid/non-opioid ANQ 3295 yes antagonist no effect non-opioid mirfentanil yes antagonist no effect non-opioid ~Self administered. 2Effect in naltrexone discrimination assay, aEffect on respiratory frequency. 4 Antagonism of analgesic effects by naltrexone.
Although the mechanism of analgesic action is not yet established for mirfentanil or ANQ 3295, these compounds might provide a novel approach to the treatment of pain, especially under conditions where the respiratory depressant effects of morphine-like opioids is contraindicated.
Second, these results demonstrate that several compounds in this series vary markedly in opioid efficacy. Finally, these studies reinforce the utility of hypothesis testing based on receptor theory, especially as that theory applies to behavioral effects of drugs.
